English | Español

Technology/Innovation
+ Technology/Innovation
Keri Carbaugh | Jan 12, 2017

Elanco's acquisition of rabies vaccines portfolio is complete
+ Technology/Innovation
Keri Carbaugh | Jan 6, 2017

Kidney Health Alliance expands to include CCX140
+ Technology/Innovation
Keri Carbaugh | Jan 5, 2017

Pfizer acquires Zaficefta, related drugs from AstraZeneca
+ Technology/Innovation
Keri Carbaugh | Jan 5, 2017

Trials of oral drug show promise in fighting pediatric tumors
+ Technology/Innovation
Carol Ostrow | Jan 2, 2017

American Cancer Society lists 2016’s impact drugs
+ Technology/Innovation
Ruth de Jauregui | Dec 29, 2016

Michael J. Fox Foundation reviews successes of 2016
+ Technology/Innovation
Jeff Gantt | Dec 28, 2016

Study reveals high pain tolerance could mask heart attacks
+ Technology/Innovation
Keri Carbaugh | Dec 27, 2016

Research accelerated for improved TB tests, vaccines

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes